Medical therapy for recurring catamenial pneumothorax following pleurodesis.

Abstract

BACKGROUND:

Catamenial pneumothorax, a rare complication of systemic endometriosis, has been difficult to treat successfully. Successful medical therapy is associated with amenorrhea.

CASE:

A 44-year-old white woman with recurring catamenial pneumothorax underwent thoracotomy and abrasive pleurodesis. Following the procedures, pneumothorax occurred again and she was treated with the GnRH analogue leuprolide acetate, 3.75 mg monthly intramuscularly. After 6 months, her therapy was changed to continuous hormonal suppression with norethindrone, 0.7 mg/day. After 6 months of this therapy and into the third episode of vaginal bleeding, the patient had another recurrent pneumothorax.

CONCLUSION:

Leuprolide acetate followed by continuous hormonal suppression with norethindrone was successful for 1 year in resolving recurring postsurgical catamenial pneumothorax, but the problem recurred with the resumption of vaginal bleeding during progestin therapy. Successful medical therapy requires amenorrhea.

• Authors: R L Dotson, C M Peterson, R C Doucette, R Quinton, D Y Rawson, K P Jones
• Journal: Obstetrics and gynecology (Obstet Gynecol) Vol. 82 Issue 4 Pt 2 Suppl Pg. 656-8 (Oct 1993) ISSN: 0029-7844 [Print] United States
• PMID: 8378002 (Publication Type: Case Reports, Journal Article)

Chemical References

• Leuprolide

Topics

• Adult
• Female
• Humans
• Leuprolide (therapeutic use)
• Menstruation
• Pleura (surgery)
• Pneumothorax (etiology, therapy)
• Recurrence